The requirements derived from the second use case of personalized medicine capture important privacy-related features
to protect the owner of PHR data, that is, the patient. Privacy is about the ability of the data owners to selectively reveal data
to interested actors and to be assured that, once shared, their data cannot be used improperly (e.g. for commercial purpose
or for extracting sensitive information about the patient).